Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047904 · ClinicalTrials.gov registry record · NA
Anesthetizing the Tympanic Membrane in Healthy Volunteers
A NA study of Evaluate Performance and Reliability of Iontophoresis System, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01047904: Completed NA study of Evaluate Performance and Reliability of Iontophoresis System, sponsored by Integra LifeSciences Corporation.
NCT01047904 is a NA study of Evaluate Performance and Reliability of Iontophoresis System that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047904, a NA study of Evaluate Performance and Reliability of Iontophoresis System, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate the performance and reliability of minor design changes to the Acclarent Iontophoresis System components for anesthetizing the tympanic membrane in healthy volunteers. Data collected from this study will enable the development of future applications and technology.
Primary Outcome
Evaluation of the performance and reliability of the Acclarent Iontophoresis System in delivery of local anesthesia to the TM in healthy volunteers
Conditions Studied
Interventions
- DEVICE Acclarent Iontophoresis System
Study Locations (1)
California
- - East Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT01047904 record still lists
NCT01047904 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Evaluate Performance and Reliability of Iontophoresis System appearing as the primary indexed condition, and to 1 intervention - of which Acclarent Iontophoresis System is the first listed.
NCT01047904 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01047904 about?
NCT01047904 is a clinical study titled "Anesthetizing the Tympanic Membrane in Healthy Volunteers". The study will evaluate the performance and reliability of minor design changes to the Acclarent Iontophoresis System components for anesthetizing the tympanic membrane in healthy volunteers. Data collected from this study will enable the development of future applications and technology.
What is the current status of trial NCT01047904?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2009-08. Estimated completion is 2009-11.
What conditions does trial NCT01047904 study?
This clinical trial studies the following conditions: Evaluate Performance and Reliability of Iontophoresis System.
What interventions are being tested in trial NCT01047904?
The interventions under investigation include: Acclarent Iontophoresis System (DEVICE).
Who is sponsoring clinical trial NCT01047904?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047904 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01047904's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia